{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:20:47Z","timestamp":1792603247413,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.euros.2025.10.020","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T20:03:47Z","timestamp":1763064227000},"page":"170-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["External Validation of Nomograms for Predicting Pelvic Lymph Node Metastases in Patients with Prostate Cancer and the Added Value of the Prostate-specific Membrane Antigen Positron Emission Tomography\u2013based PRIMARY Score"],"prefix":"10.1016","volume":"82","author":[{"given":"Muhammet","family":"Demirbilek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ktu\u011f","family":"Kalender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"B\u0131y\u0131koglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serta\u00e7","family":"Asa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Akku\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130clal","family":"G\u00fcrses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levent","family":"Kabasakal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00fclent","family":"\u00d6nal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2025.10.020_b0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2024.10.006","article-title":"Pelvic lymph node dissection in prostate cancer: update from a randomized clinical trial of limited versus extended dissection","volume":"87","author":"Touijer","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.10.020_b0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer\u20142024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.10.020_b0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/JU.0000000000002758","article-title":"Clinically localized prostate cancer: AUA\/ASTRO guideline, part II: principles of active surveillance, principles of surgery, and follow-up","volume":"208","author":"Eastham","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2025.10.020_b0020","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2011.10.044","article-title":"Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores","volume":"61","author":"Briganti","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.10.020_b0025","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.eururo.2017.03.049","article-title":"Development and internal validation of a novel model to identify the candidates for extended pelvic lymph node dissection in prostate cancer","volume":"72","author":"Gandaglia","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.10.020_b0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.eururo.2011.01.016","article-title":"Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement","volume":"60","author":"Godoy","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.10.020_b0035","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.eururo.2018.10.012","article-title":"A novel nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies","volume":"75","author":"Gandaglia","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.10.020_b0040","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.euros.2025.10.020_b0045","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/JU.0000000000001698","article-title":"A Phase 2\/3 prospective multicenter study of the diagnostic accuracy of prostate specific membrane antigen PET\/CT with 18F-DCFPyL in prostate cancer patients (OSPREY)","volume":"206","author":"Pienta","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euros.2025.10.020_b0050","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.euo.2023.03.010","volume":"6","author":"Vis","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euros.2025.10.020_b0055","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12967-017-1333-2","article-title":"Comparison of 68Ga-PSMA-11 PET-CT with mpMRI for preoperative lymph node staging in patients with intermediate to high-risk prostate cancer","volume":"15","author":"Zhang","year":"2017","journal-title":"J Transl Med"},{"key":"10.1016\/j.euros.2025.10.020_b0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bju.15134","article-title":"Histological comparison between predictive value of preoperative 3-T multiparametric MRI and 68Ga-PSMA PET\/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer","volume":"127","author":"Franklin","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2025.10.020_b0065","first-page":"1644","article-title":"The PRIMARY score: using intraprostatic 68Ga-PSMA PET\/CT patterns to optimize prostate cancer diagnosis","volume":"63","author":"Emmett","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euros.2025.10.020_b0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS Prostate Imaging-Reporting and Data System: 2015, version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.10.020_b0075","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate Imaging Reporting and Data System version 2.1: 2019 update of Prostate Imaging Reporting and Data System version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.10.020_b0080","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/apm.12533","article-title":"International Society of Urological Pathology (ISUP) grading of prostate cancer \u2013 an ISUP consensus on contemporary grading","volume":"124","author":"Egevad","year":"2016","journal-title":"APMIS"},{"key":"10.1016\/j.euros.2025.10.020_b0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41585-020-0287-y","article-title":"Considering the role of radical prostatectomy in 21st century prostate cancer care","volume":"17","author":"Costello","year":"2020","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euros.2025.10.020_b0090","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/bju.15220","article-title":"Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion","volume":"127","author":"Oderda","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2025.10.020_b0095","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/iju.14802","article-title":"Validation of models predicting lymph node involvement probability in patients with prostate cancer","volume":"29","author":"Blas","year":"2022","journal-title":"Int J Urol"},{"key":"10.1016\/j.euros.2025.10.020_b0100","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.euo.2018.04.016","article-title":"External validation of models predicting the probability of lymph node involvement in prostate cancer patients","volume":"1","author":"Hueting","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euros.2025.10.020_b0105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/MNM.0000000000000942","article-title":"Can SUVmax values of Ga-68-PSMA PET\/CT scan predict the clinically significant prostate cancer?","volume":"40","author":"Kabasakal","year":"2019","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.euros.2025.10.020_b0110","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00259-017-3631-6","article-title":"68Ga-PSMA-11 PET\/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour","volume":"44","author":"Uprimny","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euros.2025.10.020_b0115","first-page":"58","article-title":"The role of 68Ga-PSMA PET\/CT scan in patients with prostate adenocarcinoma who underwent radical prostatectomy","volume":"18","author":"Gultekin","year":"2020","journal-title":"Urol J"},{"key":"10.1016\/j.euros.2025.10.020_b0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/RLU.0000000000004951","article-title":"The PRIMARY score: diagnostic performance and added value compared with MRI in detecting clinically significant prostate cancer","volume":"49","author":"Guo","year":"2024","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.euros.2025.10.020_b0125","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00259-023-06556-y","article-title":"Prediction of clinically significant prostate cancer by [68Ga]Ga-PSMA-11 PET\/CT: a potential tool for selecting patients for active surveillance","volume":"51","author":"Akcay","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euros.2025.10.020_b0130","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.euo.2021.03.006","article-title":"Limited versus extended pelvic lymph node dissection for prostate cancer: a randomized clinical trial","volume":"4","author":"Touijer","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euros.2025.10.020_b0135","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.eururo.2020.11.040","article-title":"Extended versus limited pelvic lymph node dissection during radical prostatectomy for intermediate- and high-risk prostate cancer: early oncological outcomes from a randomized phase 3 trial","volume":"79","author":"Lestingi","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2025.10.020_b0140","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.euo.2023.05.003","volume":"6","author":"Gandaglia","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euros.2025.10.020_b0145","doi-asserted-by":"crossref","unstructured":"Gandaglia G, Barletta F, Scuderi S, et al. External validation of nomograms for the identification of pelvic nodal dissection candidates among prostate cancer patients with negative preoperative prostate-specific membrane antigen positron emission tomography. Eur Urol Oncol. In press. https:\/\/doi.org\/10.1016\/j.euo.2025.01.004.","DOI":"10.1016\/j.euo.2025.01.004"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168325019500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168325019500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T08:04:03Z","timestamp":1766131443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168325019500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":29,"alternative-id":["S2666168325019500"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2025.10.020","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"External Validation of Nomograms for Predicting Pelvic Lymph Node Metastases in Patients with Prostate Cancer and the Added Value of the Prostate-specific Membrane Antigen Positron Emission Tomography\u2013based PRIMARY Score","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2025.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}